WALTER V. KLEMP - 11 Jul 2021 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
CEO and President, Director
Signature
/s/ Walter V. Klemp
Issuer symbol
MBRX
Transactions as of
11 Jul 2021
Transactions value $
-$11,445
Form type
4
Filing time
12 Jul 2021, 17:57:44 UTC
Previous filing
06 Jul 2021
Next filing
17 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBRX Common Stock Options Exercise +13.2K +7.24% 196K 11 Jul 2021 Direct F1
transaction MBRX Common Stock Tax liability -$11.4K -3.22K -1.64% $3.56 192K 11 Jul 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Restricted Stock Units Options Exercise $0 -13.2K -1.85% $0.00 701K 11 Jul 2021 Common Stock 13.2K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
F3 On July 11, 2019, the reporting person was granted 52,818 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.